Will uterus tumor develop into cancer?

Memomas are the most common benign neoplasms in female genitals, with a high incidence among women of reproductive age. Many women tend to worry when they learn that they have uterus tumours, and one of the most serious concerns is whether it becomes cancer. So, do uterus tumors develop into cancer? This requires an in-depth understanding of the properties of the uterus membrane and its associated factors. First, let’s get to know the uterus. It is mainly a result of the growth of smooth muscle cells, with small fibre-laying tissues. Most patients with uterine membrane have no apparent symptoms and are detected only incidentally during a medical examination or for other gynaecological reasons. Common symptoms include increased menstruation, longer menstruation, abdominal swelling, urine frequency, urination, constipation, etc. The appearance of these symptoms is related to the size, number, location and impact on the normal physiology of the uterus. The growth of uterine aboma is closely related to the levels of estrogen and gestational hormone in women in terms of the onset of the disease. During the reproductive years, female estrogen and gestational hormones are relatively active, providing some “soil” for the growth of myooma. For example, during pregnancy, hormonal levels in the body are significantly higher and myoomas are likely to increase rapidly; after menopausal periods, as hormone levels decline, myomas tend to stop growing or even contract. Although uterus tumours are benign tumours, there is a real possibility of malformation, although the probability is very low, usually between 0.4 and 0.8 per cent. Malignant myooma, known as uterus tumour, is a more malignant tumour with relatively poor prognosis. So, what factors can contribute to the uterine aboma? Age is an important factor. There is a relatively high risk of musculoma malformation in women during or after menopausal periods. This is because, at this stage, the hormonal environment in women has changed, and myoomas are more likely to change with unstable hormones. The size and growth rate of myooma are also of concern. If a mesothelioma increases rapidly in the short term, for example, by more than six weeks in diameter within half a year, or by more than 10 centimetres in diameter, the likelihood of malformation increases. In addition, the visual characteristics of myoma can provide some clues. An ultrasound examination also needs to be wary of the potential for malformations if it reveals an uneven internal response to myooma, unclear boundaries, abundant blood flow, or abnormalities such as cystic changes, bad deaths, etc. How can women with uterus tumours be monitored for malignation? Regular gynaecological examinations are essential. It is generally recommended that a gynaecology ultrasound be performed every 3 – 6 months to observe changes in the size, morphology, quantity and internal echoes of myooma. At the same time, gynaecologists are also concerned about the symptoms of patients, such as whether menstruation has increased suddenly, whether abdominal pains have occurred, and whether abdominal tracts have been felt. If there are signs of suspected malignation of myoomas, further examinations such as MRI, oncology markers (e.g. CA125, etc.) may be used and, if necessary, surgical detection is required to determine the nature of myooma through a pathological examination. If the uterus musculoma is diagnosed as a malformation, i.e. the uterus tumour, the treatment is usually based on surgery, including hysterectomy and bi-sided appendectomy, as well as, if necessary, lymphomy by the pelvic cavity and abdominal aorthesia. After the operation, supplementary chemotherapy or treatment may be required to improve the survival and quality of life of the patient, depending on the pathology and the patient ‘ s circumstances. Despite the low chance of uterus tumours changing, women friends are still unable to take care of themselves. In daily life, a healthy lifestyle is maintained, such as balanced diet, adequate exercise, reduction of stress, etc., in order to maintain relative stability of hormonal levels in the body. For women with uterus tumours, periodic reviews are carried out in strict compliance with the doctor ‘ s recommendations, and the changes in uterine tumours are closely monitored. In the event of an anomaly, medical treatment and further examination and treatment are performed in a timely manner. Only in this way can women ‘ s reproductive health be guaranteed to the greatest extent possible, even in the face of the common disease of uterus tumours, so that early detection, early diagnosis and early treatment can be avoided with serious consequences.